On Thursday, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. The molnupiravir tablet will be taken twice daily by vulnerable patients who have recently been diagnosed with COVID-19.
Merck’s antiviral pill for Covid-19 has been granted its first authorisation for use by the UK medicines regulator. The drug has been hailed by public health experts as an important new tool to combat the pandemic
Covid patients could soon be given a pill to help them get better after UK regulators approved the world’s first oral anti-viral treatment for the disease.
What people are saying?
Allan glass Great news from manufacturer Merk, you know the company that makes Ivermectin, just a pity there is a bout £500 diffrence in the cost of each tablet. So it means we can control the hospitalisations now with a 50% reduction and protect the NHS, so do we need to still mandate stuff?
doCrypto Molnupiravir is manufactured by Merck, same company that makes Ivermectin. The new drug is basically same as the old. Only difference is the new one costs a fortune and the old one very cheap. That’s why the new drug has been sanctioned and not the old.